Discover 39 paid clinical trials in Dothan, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 39
Featured
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & Responsive
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
for
ADHD, Anxiety, Generalized Anxiety, Social Anxiety Disorder
Location: 44 recruiting locations
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
for
Ulcerative Colitis
Location: 47 recruiting locations
Sponsor: Takeda
Sex: All
Age: 18 - 65
Code: NCT06095128
Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: 79 recruiting locations
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819878
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: 133 recruiting locations
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: 143 recruiting locations
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase3, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
for
Moderately to Severely Active Ulcerative Colitis
Location: 80 recruiting locations
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06589986
Phase3, Recruiting
Active & Responsive
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
for
Asthma
Location: 99 recruiting locations
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Sex: All
Age: 4+
Code: NCT06052267
Phase3, Recruiting
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder